Skip to main content
Premium Trial:

Request an Annual Quote

Telo Genomics, Mayo Clinic Collaborate on Multiple Myeloma Clinical Studies

NEW YORK – Telo Genomics said Friday it will collaborate with Mayo Clinic on clinical studies to evaluate and validate the company's proprietary telomere analytics as a prognostic solution for multiple myeloma. 

The studies were designed to include two retrospective phases, with the potential of a third prospective phase. The first phase of the studies is expected to launch in the first quarter of 2020. 

For each phase, Telo's telomere analytics will be used to predict the progression of multiple myeloma precursors to full stage multiple myeloma and predict patient responses to first-line therapy at the point of diagnosis. The studies will be led by Shaji Kumar at the Mayo Clinic in Rochester, Minnesota. 

"These studies are foundational to advance Telo-MM tests towards commercialization," Telo Genomics CEO Sherif Louis said in a statement. The company performs quantitative analysis of telomeres with a particular focus on liquid biopsy diagnostics and prognostics. It uses TeloView, a software platform, to quantify specific features of a patient's telomeres in 3-D. 

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.